Both are Dividend Kings with decades of consecutive raises, but Medtronic and Abbott reward income investors in fundamentally different ways, and choosing the wrong one in retirement could cost you more than you expect.
A privacy coin built for anonymity is outperforming Bitcoin against its own all-time high, and the reasons behind that resilience reveal something unexpected about who actually holds Monero and why they refuse to sell.
Intel just posted its strongest revenue growth in fifteen years, yet the stock carries a beta that turns any road to recovery into a white-knuckle ride. Here is what the numbers reveal about how…
We called Oklo a buy and NuScale a strong buy when nuclear fever gripped the market, and the trade collapsed spectacularly. Here is what the bull case looks like after the wreckage, and whether…
Four of these five large-cap dividend stocks just dropped sharply, pushing their yields above 6%, but a rising yield can signal opportunity or a warning sign depending on what sits beneath the payout.
Treasury just dropped its third-largest penalty in history on Bank of America hours before the bank steps up to report earnings, and the fine carries a tax twist that makes it sting harder than…
Wall Street analysts reshuffled their bets Wednesday, hitting several major tech and industrial names with surprise downgrades while selectively upgrading defense and commodity plays. Find out which stocks just got a fresh vote of…
Lowe's has doubled its quarterly dividend since 2021 and still outpaces Home Depot and Target on payout growth, but a frozen housing market and fresh acquisition debt are now squeezing the engine that makes…
Ethereum's biggest corporate buyer is weeks away from hitting its purchase limit, and ChatGPT has a specific price target for where ETH lands once that demand disappears. The answer depends on a ratio most…
Johnson and Johnson crushed earnings, raised guidance, and still watched its stock crater nearly 6% in a single session. Understanding what spooked investors reveals whether Tuesday's selloff is a trap or a warning.
AMD just posted record Data Center revenue and claims its Helios racks deliver cheaper tokens than anything NVIDIA sells. Whether that disrupts the world's most dominant AI platform or just keeps hyperscalers from paying…
Qualcomm is betting its future on AI and data center chips while its smartphone business bleeds, and the December quarter will prove whether that bet pays off or exposes a company caught between two…
Applied Materials just posted its fifth consecutive earnings beat while the stock cratered 22% in three months, and at least one Wall Street firm thinks that disconnect points to one of the more compelling…
Elon Musk just called unnamed memory makers extortionate while praising Micron's pricing as a model for long-term loyalty, but the company's own contracts tell a more complicated story about who actually controls prices.
Every big pharma company eventually watches its best-selling drug go generic, yet some keep raising their dividends anyway. The five names on this list have already replaced their fading blockbusters with something bigger, and…
